Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shionogi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects aged 18 years or older at time of informed consent with non-malignant chronic pain experiencing opioid-induced constipation
Subjects with \< 3 spontaneous bowel movements a week and experiencing bowel symptoms
Subjects receiving chronic opioid therapy due to non-malignant pain for ≥ 3 months
You may not be if
Evidence of clinically significant gastrointestinal disease
History of chronic constipation prior to starting analgesic medication or any potential non-opioid cause of bowel dysfunction that may be a major contributor to the constipation
Severe constipation that has not been appropriately managed such that the subject is at immediate risk of developing serious complications of constipation
Clareo Health | A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy
